Pfizer
PFE · NYSE
Bulios Fair Price
$41.56
50.0% upside
Current Price
$27.72
According to Bulios Fair Price, PFE is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Pfizer (PFE) is a global pharmaceutical company specializing in research, development, and manufacturing of medicinal products. With over 170 years of experience, Pfizer has become one of the most prominent players in the healthcare industry. Their innovative drugs and vaccines have a significant impact on people's health and quality of life worldwide. Pfizer stock is suitable for investors seeking stable and long-term growth in the pharmaceutical sector. Add PFE stock to your watchlist on Bulios and stay informed about the latest news and developments of this significant pharmaceutical company.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Albert Bourla
Employees
75,000
Headquarters
New York City
Upcoming events
Earnings
Upcoming earnings report